Peripheral neuropathy afflicts millions of diabetes patients around the world, causing sensations from tingling to pain to complete numbness. For our season finale, we discussed peripheral neuropathy with bioengineer Christian Metallo, whose recent research has uncovered how insulin-regulated metabolism of lipids and amino acids contributes to peripheral neuropathy. Dr. Metallo spoke with us about the inspiration for this research and explained his team’s key findings about the links between insulin, the amino acids serine and glycine, and peripheral neuropathy in diabetes patients.

Proteins, with their unique structures, have evolved over billions of years to perform a host of different functions essential to the processes that keep us alive. Using the same principles as artificial intelligence chatbots, scientists at Salesforce developed an AI language model called ProGen. Using large protein databases, ProGen was trained on the biological syntax of amino acid sequences, allowing it to design functional 3D protein structures. These proteins have useful properties that may be leveraged in healthcare and biosciences. In this episode, we talk with Dr. Nikhil Naik, Director of AI Research at Salesforce, leading the team of scientists behind ProGen. We discuss the inspiration for ProGen, the implications of AI-generated proteins, and the future of protein engineering in light of ever-evolving biotechnologies. Music credits: “Summer Lofi” and “Summer Winds” by Rukudzo.

Respiratory infections are a major cause of mortality worldwide and pose unique challenges for healthcare interventions due to the antibiotic-resistant nature of many respiratory pathogens. For patients that require ventilation, an additional complicating factor is a protective substance produced by bacteria known as a biofilm. Biofilms can result in chronic infections, preventing the body and antibiotics from clearing the bacteria away. In this episode, we talk with Dr. Maria Lluch-Senar, a biotechnologist working with engineered Mycoplasma (a type of bacteria) with the aim of leveraging it to treat disease. She shares with us why Mycoplasma is a candidate for these interventions, how her lab modifies the organism, and the process through which these bacteria will help us more effectively treat other bacterial infections. Music featured in this episode includes excerpts from “Elevator Pitch” and “What’s the Angle” by Shane Ivers.